Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany UpdateFundraise8 Aug 2026

Veefin Solutions Ltd

The Board of Directors of the company has approved for the allotment of 3,00,000 unrated, unlisted, secured, redeemable non-convertible debentures having a face value of INR 1,000/- (One ....

Veefin Solutions Ltd has announced the allotment of 3,00,000 unrated, unlisted, secured, redeemable non-convertible debentures with a face value of INR 1,000 each, aggregating to INR 30,00,00,000, to Stride Ventures Debt Fund 4 on a private placement basis.

Read more →📎 1 attachment
BSECompany UpdateFundraise8 Aug 2026

Medi Assist Healthcare Services Ltd

As enclosed

Medi Assist Healthcare Services Ltd has filed a statement of deviation or variation in the utilization of funds raised through a Preferential Issue for the quarter ended June 30, 2026, stating that there has been no deviation or variation in the use of funds raised. The company has also enclosed a Monitoring Agency Report issued by CARE Ratings Limited.

Read more →📎 1 attachment
BSECompany UpdateFundraise8 Aug 2026

Medi Assist Healthcare Services Ltd

As enclosed

Medi Assist Healthcare Services Ltd has filed a statement of deviation or variation in the utilization of funds raised through a preferential issue for the quarter ended June 30, 2026, stating that there has been no deviation or variation in the use of funds raised. The company has also enclosed a monitoring agency report issued by CARE Ratings Limited.

Read more →📎 1 attachment
BSECompany UpdateFundraise8 Aug 2026

Chemkart India Ltd

Disclosure under Regulation 30 of SEBI LOD Regulations 2015 for Acqusition of Equity Shares in Wholly-Owned Subsidiary Company.

Chemkart India Ltd has made an investment of Rs. 1.00 Crores by issuing and allotting 10,00,000 Equity Shares of face value of Rs. 10/- each at an issue price of Rs. 10/- each in Easy Raw Materials Private Limited, a Wholly Owned Subsidiary, through a Rights Issue. The acquisition is a part of the utilization of the proceeds as specified in the Prospectus dated 10th July 2025.

Read more →📎 1 attachment
BSECompany UpdateFundraise7 Aug 2026

Kesar India Ltd

Statement of Deviation and Variation

Kesar India Ltd has submitted a statement to BSE regarding the utilization of proceeds from its preferential issue, stating that there are no deviations or variations in the utilization of the proceeds during the quarter ended June 30, 2026.

Read more →📎 1 attachment
BSECompany UpdateFundraise7 Aug 2026

Deccan Gold Mines Ltd

Preferential Issue of Securities

Deccan Gold Mines Ltd has announced a preferential issue of securities, including Compulsorily Convertible Debentures (CCDs), Equity Shares, and Equity Warrants, to non-promoter entities, aggregating up to Rs. 1,84,65,46,463. The issue price is Rs. 191.90 per unit, and the securities are convertible into equity shares within 18 months, subject to shareholder and regulatory approvals.

Read more →📎 1 attachment
BSECompany UpdateFundraise7 Aug 2026

Zodiac-JRD-MKJ Ltd

Refer attached document

Zodiac-JRD-MKJ Ltd has proposed a rights issue of up to ₹40,00,00,000 to eligible equity shareholders, with a face value of ₹10 each, at an issue price of ₹ [•] per equity share.

Read more →📎 1 attachment
BSECompany UpdateFundraise7 Aug 2026

Parag Milk Foods Ltd

Monitoring Agency Report for quarter ended June 30, 2026

Parag Milk Foods Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations, regarding the utilization of funds raised through a preferential issue of convertible share warrants in May 2025. The report states that there has been no deviation from the objects of the issue.

Read more →📎 1 attachment
BSEOthersFundraise7 Aug 2026

Noble Polymers Ltd

1.Allotment of 22,76,400 Equity Shares of face value Rs. 5/- each, fully paid-up, at an issue price of Rs. 5/- per share, aggregating to Rs. 1,13,82,000/-, to persons belonging to the Proposed ....

Noble Polymers Ltd has approved the allotment of 22,76,400 equity shares and 2,34,75,735 convertible warrants to proposed promoters at Rs. 5 per share, aggregating to Rs. 1,13,82,000 and Rs. 11,73,78,675 respectively, on a preferential basis.

Read more →📎 1 attachment
BSEBoard MeetingFundraise7 Aug 2026

Alankit Ltd

1. The unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended June 30, 2026, together with the Limited Review Report thereon issued by the Statutory ....

Alankit Ltd's board of directors has approved the issue of up to 10 crore fully convertible warrants at Rs. 8.60 per warrant, aggregating up to Rs. 86 crore, to be issued on a preferential basis to promoters and public category investors. The company has also approved its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, and the annual report for the financial year 2025-26.

Read more →📎 1 attachment
← PreviousPage 143 of 177Next →